Non-small cell lung cancer (NSCLC) represents 85% of all lung cancers, with epidermal growth factor receptor (EGFR) mutations occurring in 10–30% of NSCLC patients. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.